Table 3.
Baseline demographics for Centre A versus the rest of the Netherlands.
| 12‐Month Completers | 24‐Month Completers | 36‐Month Completers | ||||
|---|---|---|---|---|---|---|
| Centre A | Rest of Netherlands | Centre A | Rest of Netherlands | Centre A | Rest of Netherlands | |
| Eyes | 257 | 446 | 153 | 220 | 74 | 97 |
| Patients | 231 | 392 | 138 | 193 | 68 | 85 |
| Gender, % female patients | 60.2% | 63.3% | 58% | 64.2% | 63.2% | 64.7% |
| Age, mean (SD) | 78.9 (9.2) | 79.2 (7.8) | 78.9 (9.1) | 78.3 (7.4) | 78 (9.9) | 77.7 (7.9) |
| VA, mean letters (SD) | 59.1 (16.2) | 59.3 (19.6) | 58.3 (15.3) | 60 (18.8) | 58.4 (14.9) | 58.9 (21.1) |
| VA ≤ 35 letters, n (%) | 21 (8.2%) | 61 (13.7%) | 13 (8.5%) | 27 (12.3%) | 5 (6.8%) | 15 (15.5%) |
| VA ≥ 70 letters, n (%) | 78 (30.4%) | 171 (38.3%) | 43 (28.1%) | 84 (38.2%) | 20 (27%) | 42 (43.3%) |
| Lesion size, median µm (Q1, Q3) | 1500 (398, 2500) | 2000 (750, 3108) | 1500 (366, 2500) | 1955 (735, 3164) | 1350 (500, 2400) | 1750 (600, 2926) |
| Angiographic lesion type, n (%) | ||||||
| Type 1 | 29 (11.3%) | 157 (35.2%) | 20 (13.1%) | 99 (45%) | 9 (12.2%) | 48 (49.5%) |
| Type 2 | 4 (1.6%) | 40 (9%) | 4 (2.6%) | 16 (7.3%) | 2 (2.7%) | 6 (6.2%) |
| Type 3 | 0 (0%) | 5 (1.1%) | 0 (0%) | 1 (0.5%) | 0 (0%) | 1 (1%) |
| Disciform scar | 0 (0%) | 3 (0.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| IPCV | 0 (0%) | 3 (0.7%) | 0 (0%) | 3 (1.4%) | 0 (0%) | 1 (1%) |
| Juxtapapillary | 8 (3.1%) | 4 (0.9%) | 2 (1.3%) | 4 (1.8%) | 1 (1.4%) | 1 (1%) |
| Not done | 216 (84%) | 234 (52.5%) | 127 (83%) | 97 (44.1%) | 62 (83.8%) | 40 (41.2%) |